Categories Analysis, Consumer

What to expect when Tyson Foods (TSN) reports Q2 earnings next week

Analysts are projecting revenue of $13.6 billion for Tyson in Q2 2023

Shares of Tyson Foods Inc. (NYSE: TSN) were down on Wednesday. The stock has dropped 6% over the past three months. The company is scheduled to report its second quarter 2023 earnings results on Monday, May 8, before market open. Here’s what to expect from the earnings report:

Revenue

Analysts are projecting revenue of $13.6 billion for Tyson in Q2 2023, which would represent an increase of nearly 4% from the same period a year ago. In the first quarter of 2023, sales increased 2.5% year-over-year to $13.2 billion.

Earnings

The consensus estimate is for EPS of $0.80 in Q2 2023, which is down from EPS of $2.29 reported in the year-ago quarter. In Q1 2023, adjusted EPS was $0.85, down 70% year-over-year.

Tyson-Foods-Q1-2023-Earnings-Infographic-1

Points to note

In the first quarter of 2023, Tyson reported sales growth helped by strength in the Chicken, Prepared Foods, and International segments. The company is optimistic on the potential of its Prepared Foods business and the strength of its retail brands in this segment. Prepared Foods has benefited from volume growth and pricing actions and this momentum is likely to continue in Q2. The Chicken segment also benefited from higher volume and pricing actions during the first quarter.

Tyson’s results in Q1 were impacted by lower demand in beef and pork. In addition, the company continues to feel the pressure of higher costs which has hurt its margins and taken a toll on its profitability. This is likely to pose a challenge in the second quarter as well.

In an effort to tackle rising costs, Tyson decided to shut down two of its poultry farms in the US and lay off nearly 1,700 workers. The company also announced that it was going to cut 10% of corporate jobs and 15% of its senior leadership team. These are significant areas to keep an eye on in the Q2 report.

Most Popular

Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent

Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1

Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three

After a positive year, what’s in the cards for Electronic Arts (EA) in FY25

Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top